article thumbnail

Biotech Roundup: ASCO, BIO, Drug Setbacks, Incubators & More

Xconomy

BIO president and CEO Jim Greenwood (pictured), a former Congressman-turned-lobbyist, told an audience, “We are fighting back,” and unveiled plans to put some of the blame for high drug prices on insurance companies. The new prices don’t reflect rebates and discounts.

article thumbnail

Makers Making The Sci-Fi Tricorder A Reality With VOXearch

socalTECH

Our first project was 3D imaging of the heart, so that doctors could study a pacemaker and defibrillator recall from the Alfred E. Unfortunately, those providers decided the gold leads were expensive, and decided to use a Chinese vendor which would provide them at half price. I''ve worked in the movie business, movie, audio, imaging.

Startup 262